Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by guerreiroon Nov 05, 2010 11:47am

213 Views

Post# 17664126

What Price for PP??.

Management should do it above $ 1 to minimize stock dilution. Wouldn't take much to take HLO above $1.
I was hoping to see it above .50 cents at the close today. And as some of you predict $5 in a few years, it is perception that creates reality.
Best of luck .

<< Previous

Bullboard Posts

Next >>

How a world class helium discovery in Minnesota was made by chance